Hyperplasia in Medical News

Generic Erosion of Established Agents Will Offset Growth From Uptake of Emerging Therapies in the Market for Benign Prostatic Hyperplasia and Male Lower Urinary Tract Symptoms

... percent in the drug market for benign prostatic hyperplasia and male lower urinary tract symptoms in the ... new Pharmacor report entitled Benign Prostatic hyperplasia and Male Lower Urinary Tract Symptoms finds that ... disease, drug development for benign prostatic hyperplasia has focused on improving dosing convenience and ...

Hall of Fame Baseball Legend Mike Schmidt Speaks Out for the First Time About Common Health Problem in Older Men

... to raise awareness of Benign Prostatic hyperplasia (BPH), a condition affecting more than 8 ... the U.S. to raise awareness of Benign Prostatic hyperplasia (BPH), commonly known as enlarged prostate, and ... by sanofi-aventis. About Benign Prostatic hyperplasia (BPH) BPH is defined as a progressive condition ...

COX-2 expression is marker for cancer development in some benign breast biopsies

... they dont have cancer, they do have atypical hyperplasia -- cells that arent quite normal and might become ... 1991, and who were diagnosed with the atypical hyperplasia cell growth disorder. During an average ... cancer 15 years after a diagnosis of atypical hyperplasia was 13 percent in biopsies with little or no ...

Patent Expiries of Proscar and Flomax/Harnal Will Cause a Significant Decline in Near-Term Sales of Benign Prostatic Hyperplasia Drugs

... in sales of therapies to treat benign prostatic hyperplasia over the next five years. The new Pharmacor report entitled Benign Prostatic hyperplasia finds that the market to treat the disease is ... decline in the overall benign prostatic hyperplasia market by 2011. Although patent expiries will ...

Tadalafil May Effectively Treat Symptoms of BPH-LUTS in Addition to Erectile Dysfunction

... may improve lower urinary tract symptoms in men with benign prostatic hyperplasia (BPH). Researchers from Nashville, Dallas, San Antonio and Indianapolis ... obstruction index in men with signs and symptoms of benign prostatic hyperplasia treated with tadalafil. J Urol, suppl. 2009: 181, 4, abstract 1924. ...

Lumenis Introduces the HoLEP Simulator and the PolyScope Disposable Ureteroscope at American Urology Association 2009 Annual Meeting

... superior outcomes and long term durability in treating Benign Prostatic hyperplasia (BPH) of all gland sizes(2). There has been increasing interest from ... first holmium laser cleared by the FDA for treatment of Benign Prostatic hyperplasia (BPH), is also effective for surgical removal of stones, tumors and ...

Breast cancer risk varies in young women with benign breast disease, Mayo Clinic researchers say

... SAN ANTONIO - A type of benign breast disease (BBD) known as atypical hyperplasia substantially increases a young woman's risk of developing breast cancer, ... found that in the entire benign breast disease cohort, women with atypical hyperplasia were more than three times more likely to develop breast cancer. They also ...

World-Renowned Urologist, J. Francois Eid, M.D., Expands Practice with Increased Treatment of Benign Prostate Hyperplasia (BPH)

... is now expanding his practice to treat more patients with benign prostate hyperplasia (BPH) . Though he has treated many men with BPH in the past, Dr. Eid would ... highly skilled at diagnosing and treating the disease. Benign prostate hyperplasia is caused by an enlarged prostate gland, which continues to grow ...

Risk assessment tool not reliable predictor for some women at high risk of breast cancer

... the Oct. 14, 2008, issue of the Journal of Clinical Oncology . Atypical hyperplasia (atypia) describes breast tissue with an increased growth of abnormal ... well as the number of breast biopsies undergone and presence of atypical hyperplasia found in biopsies. About 5 percent of women who undergo biopsies for ...

China Sky One Medical, Inc. Acquires Drug to Treat Breast Lesions

... from Harbin Medical University. The drug is intended to treat lobular hyperplasia in women, a type of mastitis that may lead to breast cancer. It is believed that lobular hyperplasia is brought about by stress, over work, and an irregular, high-pressure ...

How molecules out of balance lead to human multiple myeloma and other cancers

... by Professor Mackay on BAFF showed that levels correlate with B cell hyperplasia (expansion) and cancer. The current study shows that if we have too much ... to go up, but its function is going to be changed. This can lead to B cell hyperplasia and cancer." "Our paper is saying 'be careful'! Sometimes you can find ...

AEterna Zentaris Announces First Patient Dosing for Safety Trial of Phase 3 Program with Cetrorelix in Benign Prostatic Hyperplasia

... study of the Company's Phase 3 program with cetrorelix in benign prostatic hyperplasia (BPH). Cetrorelix, a novel investigational luteinizing ... regulatory agencies. Benign Prostatic Hyperplasia Benign prostatic hyperplasia (BPH) is one of the most common diseases of aging men - affecting more ...

Lumenis Launches HoLEP Preceptor Program at American Urology Association 2008 Annual Meeting

... that HoLEP provides superior outcomes in treating Benign Prostatic hyperplasia (BPH) of all gland sizes(1). For large prostates, HoLEP is a surgical ... first holmium laser cleared by the FDA for treatment of Benign Prostatic hyperplasia (BPH), is also effective for surgical removal of kidney stones, bladder ...

Enlarged Prostate Treatment Study Shows Combination of AVODART(R) and Tamsulosin Provides Greater Benefit Than Either Medication Alone

... d'Urologie in Paris. Enlarged prostate (also known as benign prostatic hyperplasia or BPH) is a progressive disease that affects 50 percent of men over the ... Therapy on Lower Urinary Tract Symptoms in Men with Benign Prostatic hyperplasia and Prostatic Enlargement: 2 Year Results from the CombAT Study. J ...

biolitec AG - Record Profit in FY 2006/07 With a Growth of 191% to Euro 6,7 Million

... power. For the first time, patients suffering from benign prostate hyperplasia can be treated in office with biolitec's urology laser LIFE (Laser Induced ... and impotence. The laser is the only possibility to treat benign prostate hyperplasia in office without extensive anaesthesia. First LIFE Laser Centers have ...

QuatRx Announces Further Positive Phase 3 Results For Ophena(TM) (Ospemifene Tablets) in Postmenopausal Vaginal Atrophy

... No trends were apparent in severe treatment-emergent adverse events and no cases of pelvic organ prolapse, venous thromboembolism, endometrial hyperplasia or carcinoma were observed. Overall, the results of this double-blind, placebo-controlled, long-term safety extension study demonstrated that daily ...

Study Evaluating Efficacy and Safety of Two Low-dose Regimens of PREMARIN Vaginal Cream for the Treatment of Moderate to Severe Vaginal Atrophy Now Published

... safety was assessed in women who completed the 52-week study period and had evaluable endometrial biopsies. There were no reports of endometrial hyperplasia or endometrial carcinoma in these women in either regimen. In this study, the most common treatment emergent AE's were headache, infection, ...

For Men Over 50, Odds of Eye Discomfort Increases

... and colleagues noted in the June issue of the Archives of Ophthalmology . Among men, increasing age, high blood pressure, benign prostatic hyperplasia (a noncancerous enlargement of the prostate) and the use of antidepressants increase the chances of developing dry eye disease, the study authors ...

Researchers identify 4 new targets for breast cancer

... mice developed mammary gland cancer. Only one case of inflammation and two cases of a potentially precancerous accumulation of cells known as hyperplasia were noted. Cancer incidence ranged from 32 percent to 52.8 percent in the four strains of mice with one of the culprit receptors or autotaxin. ...

Researchers identify four new targets for breast cancer

... mice developed mammary gland cancer. Only one case of inflammation and two cases of a potentially precancerous accumulation of cells known as hyperplasia were noted. Cancer incidence ranged from 32 percent to 52.8 percent in the four strains of mice with one of the culprit receptors or autotaxin. ...

Enlarged Prostate and Erectile Dysfunction Are Subjects of Free Men's Health Seminar

... 8:30 AM at El Dorado Hospital, will explain the latest treatment options for two of the most common conditions affecting men today: Benign Prostate hyperplasia (also known as Enlarged Prostate) and Erectile Dysfunction. A question and answer period will follow the program. At the June 6th presentation, ...

Watson Launches GELNIQUE(TM) (oxybutynin chloride) Gel 10%, First and Only Topical Gel for Overactive Bladder (OAB)

... Watson recently launched RAPAFLO (TM) (silodosin), the Company's new alpha blocker for the treatment of the signs and symptoms of benign prostatic hyperplasia (BPH), which offers rapid relief and has an exceptional safety profile. The Company also has submitted a New Drug Application for its 6-month ...

Neurocrine Announces Full Year Results from 603 Study (Petal Study) of Elagolix for Treatment of Endometriosis Pain

... pharmaceutical markets in the world including endometriosis, irritable bowel syndrome (IBS), anxiety, depression, pain, diabetes, benign prostatic hyperplasia (BPH) and other neurological and endocrine related diseases and disorders. Neurocrine Biosciences, Inc. news releases are available through the ...

Light Sciences Oncology Announces Results of Study on Immunotherapeutic Mechanism of Aptocine(TM), a Novel Light-Activated Drug Therapy for Cancer

... 3 trial for metastatic colorectal cancer (MCRC). LSO has also completed a Phase 1/2 trial and has initiated a Phase 2a trial in benign prostatic hyperplasia (BPH), or enlargement of the prostate, and has clinical or preclinical programs in cardiovascular disease, eye disease, neurofibromatosis, and ...

Research Findings on Nine GlaxoSmithKline Cancer Compounds to be Presented at ASCO 2009

... reductase isoenzymes has not been established. Dutasteride is indicated for the treatment of moderate-to-severe symptoms of benign prostatic hyperplasia (BPH) in men with an enlarged prostate. It has been shown to improve urinary symptoms, reduce the risk of acute urinary retention (AUR), and the risk ...

AEterna Zentaris Reports First Quarter 2009 Financial and Operating Results

... ended March 31, 2009. First Quarter 2009 Highlight Signing of partnership with sanofi-aventis for cetrorelix in benign prostatic hyperplasia ("BPH") for the U.S. market: - Initial $30 million upfront payment to the Company; - Up to $135 million in additional payments upon ...

Watson Pharmaceuticals Reports First Quarter 2009 Results; Raises 2009 Outlook

... of Rapaflo(TM) (silodosin), our new selective alpha-blocker that provides rapid and sustained relief of the signs and symptoms of benign prostatic hyperplasia (BPH)." "Based on our first quarter results and our view for the remainder of the year, we are raising our outlook for 2009, a clear signal that ...

Neurocrine Biosciences Announces Conference Call and Webcast to Present First Quarter 2009 Financial Results

... address some of the largest pharmaceutical markets in the world including endometriosis, anxiety, depression, pain, diabetes, benign prostatic hyperplasia (BPH), irritable bowel syndrome (IBS) and other neurological and endocrine related diseases and disorders. Neurocrine Biosciences, Inc. news releases ...

Prostate Study Shows BOTOX May Be Safe, Effective Method for Managing Benign Prostatic Hyperplasia

... dose levels of Botulinium Neurotoxin Type A (BOTOX) injected into the prostate was both safe and efficacious for the management of benign prostatic hyperplasia (BPH), a common noncancerous enlargement of the prostate that can cause difficulty in urination. "People often underestimate the significant ...

Tadalafil may effectively treat symptoms of BPH-LUTS in addition to erectile dysfunction

... LINTHICUM, MD, April 26, 2009Tadalafil may improve lower urinary tract symptoms in men with benign prostatic hyperplasia (BPH). Researchers from Nashville, Dallas, San Antonia and Indianapolis will present these findings during the 104th Annual Scientific Meeting of the ...

Harvard Medical School Prostate Disease Website Guides Patients Through Decision-Making Process

... The new website provides multiple perspectives on how best to treat prostate disease, including prostate cancer, benign prostatic hyperplasia (BPH), and prostatitis, as well as erectile dysfunction and low testosterone levels. "The public continues to be presented with conflicting ...

Free Community Seminar; Reviews Treatment Options for Enlarged Prostate

... prostate will be the focus of a free community seminar on April 2, 2009 at 6:30pm at the Doubletree Hotel in Rosemead. Also known as benign prostatic hyperplasia (BPH), this non-cancerous enlargement of the prostate affects more than half of all men over the age of 60 and more than 26 million men in the United ...

Free Community Seminar to Review Treatment Options for Enlarged Prostate

... of a free community seminar on March 28, 2009 at 2:00pm at the Chestnut Hill Hospital Auditorium in Philadelphia. Also known as benign prostatic hyperplasia (BPH), this non-cancerous enlargement of the prostate affects more than half of all men over the age of 60 and more than 26 million men in the United ...

High Intensity Focused Ultrasound Physician Training Seminar in Mexico City

... Leading HIFU device in Mexico for Minimally Invasive Treatment for Prostate Cancer and Benign Prostatic hyperplasia draws attention from elite urologists CHARLOTTE, N.C., March 16 /PRNewswire/ -- Mexico HIFU in conjunction with International HIFU, the Mexican ...

Drugs May Help Healthy Men Lower Prostate Cancer Risk

... discuss continuing the medication as a way to prevent prostate cancer. Today, 5-ARIs are used to treat male-pattern baldness and benign prostatic hyperplasia (enlarged prostate) among other non-cancerous conditions. While supporting the guidelines, panel co-chair Dr. Paul F. Schellhammer noted that ...

A potential molecular target for biotherapy esophageal squamous cell carcinomas

... Fan from China detected the expression of E-cadherin and N-cadherin in 62 cases of normal esophageal epithelium, 31 cases of adjacent atypical hyperplasia epithelium and 62 cases of esophageal squamous cell carcinoma.Their study will be published on February 14, 2009 in the World Journal of ...

Intermittent Catheter Market to Surpass 40% CAGR Between 2008 and 2012

... reimbursement, as well as numerous other urological device markets in the areas of incontinence, prostate cancer, stone management, benign prostatic hyperplasia (BPH), and erectile dysfunction (ED). Coverage of key industry competitors includes American Medical Systems, C.R. Bard, Caldera Medical, Cook ...

Women's cancer outcomes improved by surgical evaluation

... community hospitals across Alabama from 1999 to 2008. They specifically looked women diagnosed with pre-cancerous changes called complex atypical hyperplasia (CAH). Of patients who underwent a traditional hysterectomy, about half were found to have invasive endometrial cancer after their procedure. That ...

Free Community Seminar to Review Treatment Options for Enlarged Prostate

... be the focus of a free community seminar on February 20, 2009 at 6:30pm at the Hampton Inn & Suites in Mercer. Also known as benign prostatic hyperplasia (BPH), this non-cancerous enlargement of the prostate affects more than half of all men over the age of 60 and more than 26 million men in the United ...

AUA Annual Scientific Meeting features more new research than ever before

... than 2,000 investigators will present their latest research on topics in urology, including prostate, bladder and kidney cancer; benign prostatic hyperplasia (BPH, or enlarged prostate); and other genitourinary diseases and conditions. Researchers are also expected to present new information regarding ...